Broe P J, Conley C L, Cameron J L
Surg Gynecol Obstet. 1981 Apr;152(4):488-92.
The records of 28 patients undergoing splenectomy for myeloid metaplasia were reviewed. Portal and mesenteric venous thrombosis was proved or suspected in five patients. The time interval between splenectomy and portal and mesenteric venous thrombosis varied from six days to three years. The incidental postmortem finding of portal vein thrombosis in one patient suggests that the incidence may be greater than clinically appreciated and may, at times, be asymptomatic. Postsplenectomy thrombocytosis was not found to be a significant risk factor, occurring in only one of the five patients in whom portal vein thrombosis developed. Recommendations for prevention include ligation of the splenic vein close to its junction with the inferior mesenteric vein at the time of splenectomy. In addition, prophylactic anticoagulation therapy or the use of antiplatelet drug therapy postoperatively, or both, should be considered.
回顾了28例因骨髓化生而行脾切除术患者的记录。5例患者被证实或怀疑存在门静脉和肠系膜静脉血栓形成。脾切除术后至门静脉和肠系膜静脉血栓形成的时间间隔从6天至3年不等。1例患者尸检时偶然发现门静脉血栓形成,提示其发病率可能高于临床认识,且有时可能无症状。脾切除术后血小板增多症未被发现是一个显著的危险因素,在发生门静脉血栓形成的5例患者中仅1例出现。预防建议包括在脾切除时靠近脾静脉与肠系膜下静脉的交界处结扎脾静脉。此外,应考虑术后预防性抗凝治疗或使用抗血小板药物治疗,或两者兼用。